Cognitive variability in bipolar II disorder: WHO is cognitively impaired and who is preserved

Bipolar Disorders

Volumn 18, Issue 3, 2016, Pages 288-299

  Solé, Brisa ^a   Jiménez, Esther ^a   Torrent, Carla ^a   del Mar Bonnin, Caterina ^a   Torres, Imma ^a   Reinares, María ^a   Priego, Ángel ^b   Salamero, Manel ^a   Colom, Francesc ^a   Varo, Cristina ^a   Vieta, Eduard ^a   Martínez Arán, Anabel ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Bipolar II disorder; Cluster analysis; Neurocognition

Indexed keywords

ADULT; AGE; ARTICLE; BIPOLAR II DISORDER; COGNITION; COGNITION ASSESSMENT; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE SEVERITY; EDUCATIONAL STATUS; FEMALE; FUNCTIONAL STATUS; HUMAN; INTELLIGENCE QUOTIENT; LEISURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; BIPOLAR DISORDER; CLASSIFICATION; COGNITION DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOMETRY; REFERENCE VALUE; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; BIPOLAR DISORDER; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; REFERENCE VALUES; YOUNG ADULT;

EID: 84969824493     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/bdi.12385     Document Type: Article

References (75)

1. Bora E, Yucel M, Pantelis C, Berk M. Meta-analytic review of neurocognition in bipolar II disorder. Acta Psychiatr Scand 2011; 123: 165-174.
2. Sole B, Martinez-Aran A, Torrent C et al. Are bipolar II patients cognitively impaired? A systematic review. Psychol Med 2011; 28: 1-13.
3. Bora E, Yucel M, Pantelis C. Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives. J Affect Disord 2009; 113: 1-20.
4. Torres IJ, Boudreau VG, Yatham LN. Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis. Acta Psychiatr Scand Suppl 2007; 434: 17-26.
5. Martinez-Aran A, Vieta E, Torrent C et al. Functional outcome in bipolar disorder: the role of clinical and cognitive factors. Bipolar Disord 2007; 9: 103-113.
6. Martino DJ, Marengo E, Igoa A et al. Neurocognitive and symptomatic predictors of functional outcome in bipolar disorders: a prospective 1 year follow-up study. J Affect Disord 2009; 116: 37-42.
7. Depp CA, Mausbach BT, Harmell AL et al. Meta-analysis of the association between cognitive abilities and everyday functioning in bipolar disorder. Bipolar Disord 2012; 14: 217-226.
8. Bonnin CM, Martinez-Aran A, Torrent C et al. Clinical and neurocognitive predictors of functional outcome in bipolar euthymic patients: a long-term, follow-up study. J Affect Disord 2010; 121: 156-160.
9. Burdick KE, Goldberg JF, Harrow M. Neurocognitive dysfunction and psychosocial outcome in patients with bipolar I disorder at 15-year follow-up. Acta Psychiatr Scand 2010; 122: 499-506.
10. Rosa AR, Bonnin CM, Vazquez GH et al. Functional impairment in bipolar II disorder: is it as disabling as bipolar I? J Affect Disord 2010; 127: 71-76.
11. Berk M, Dodd S. Bipolar II disorder: a review. Bipolar Disord 2005; 7: 11-21.
12. Vieta E, Suppes T. Bipolar II disorder: arguments for and against a distinct diagnostic entity. Bipolar Disord 2008; 10: 163-178.
13. Caseras X, Lawrence NS, Murphy K, Wise RG, Phillips ML. Ventral striatum activity in response to reward: differences between bipolar I and II disorders. Am J Psychiatry 2013; 170: 533-541.
14. Li CT, Hsieh JC, Wang SJ et al. Differential relations between fronto-limbic metabolism and executive function in patients with remitted bipolar I and bipolar II disorder. Bipolar Disord 2012; 14: 831-842.
15. Caseras X, Murphy K, Lawrence NS et al. Emotion regulation deficits in euthymic bipolar I versus bipolar II disorder: a functional and diffusion-tensor imaging study. Bipolar Disord 2015; 17: 461-470.
16. Fletcher K, Parker G, Manicavasagar V. The role of psychological factors in bipolar disorder: prospective relationships between cognitive style, coping style and symptom expression. Acta Neuropsychiatr 2014; 26: 81-95.
17. Coryell WH. Bipolar II disorder: reasons to recognize. J Clin Psychiatry 2015; 76: e222-e223.
18. Martino DJ, Strejilevich SA, Scapola M et al. Heterogeneity in cognitive functioning among patients with bipolar disorder. J Affect Disord 2008; 109: 149-156.
19. Reichenberg A, Harvey PD, Bowie CR et al. Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders. Schizophr Bull 2009; 35: 1022-1029.
20. Burdick KE, Russo M, Frangou S et al. Empirical evidence for discrete neurocognitive subgroups in bipolar disorder: clinical implications. Psychol Med 2014; 44: 3083-3096.
21. Yatham LN, Torres IJ, Malhi GS et al. The International Society for Bipolar Disorders-Battery for Assessment of Neurocognition (ISBD-BANC). Bipolar Disord 2010; 12: 351-363.
22. Vieta E. Pros and cons of specialised care in bipolar disorder: an international perspective. Br J Psychiatry 2013; 202: 170-171.
23. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
24. Ramos-Brieva JA, Cordero VA. Validation of the Castillian version of the hamilton rating scale for depression. Actas Luso Esp Neurol Psiquiatr Cienc Afines 1986; 14: 324-334.
25. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429-435.
26. Colom F, Vieta E, Martinez-Aran A et al. Spanish version of a scale for the assessment of mania: validity and reliability of the Young Mania Rating Scale. Med Clin (Barc) 2002; 119: 366-371.
27. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID I). New York: Biometrics Research, New York State Psychiatric Institute, 1997.
28. Rosa AR, Sanchez-Moreno J, Martinez-Aran A et al. Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clin Pract Epidemol Ment Health 2007; 3: 5.
29. Grande I, Magalhaes PV, Chendo I et al. Staging bipolar disorder: clinical, biochemical, and functional correlates. Acta Psychiatr Scand 2014; 129: 437-444.
30. Pinho M, Sehmbi M, Cudney LE et al. The association between biological rhythms, depression, and functioning in bipolar disorder: a large multi-center study. Acta Psychiatr Scand 2016; 133: 102-108.
31. Sole B, Bonnin CM, Mayoral M et al. Functional remediation for patients with bipolar II disorder: improvement of functioning and subsyndromal symptoms. Eur Neuropsychopharmacol 2015; 25: 257-264.
32. Weschler D. The Wechsler Adult Intelligence Scale -III (WAIS-III), San Antonio, TX: Psychological Corporation, 1997.
33. Benton AL, Hamsher K. Multilingual Aphasia Examination. Iowa City: University of Iowa, 1976.
34. Reitan RM. Validity of the Trailmaking Test as an indication of organic brain damage. Percept Mot Skills 1958; 8: 271-276.
35. Delis DC, Kramer JH, Kaplan E, Ober B. California Verbal Learning Test. New York: Psychological Corporation, 1987.
36. Rey A. Test de copia de una figura compleja: Manual Adaptación Española. Madrid: TEA ediciones, 1997.
37. Heaton RK. Wisconsin Card Sorting Test Manual. Odessa: Psychological Assessment Resources, 1981.
38. Golden CJ. Stroop Colour and Word Test. Chicago: Stoelting, 1978.
39. Conners CK. Conner's Continuous Performance Test for Windows (CPT-II). Tonawanda, NY: Multi-Health Systems Inc., 2000.
40. Martino DJ, Strejilevich SA, Marengo E, Ibanez A, Scapola M, Igoa A. Toward the identification of neurocognitive subtypes in euthymic patients with bipolar disorder. J Affect Disord 2014; 167: 118-124.
41. Hsiao YL, Wu YS, Wu JY et al. Neuropsychological functions in patients with bipolar I and bipolar II disorder. Bipolar Disord 2009; 11: 547-554.
42. Simonsen C, Sundet K, Vaskinn A et al. Neurocognitive profiles in bipolar I and bipolar II disorder: differences in pattern and magnitude of dysfunction. Bipolar Disord 2008; 10: 245-255.
43. Torrent C, Martinez-Aran A, Daban C et al. Cognitive impairment in bipolar II disorder. Br J Psychiatry 2006; 189: 254-259.
44. Dittmann S, Hennig-Fast K, Gerber S et al. Cognitive functioning in euthymic bipolar I and bipolar II patients. Bipolar Disord 2008; 10: 877-887.
45. López-Jaramillo C, Lopera-Vásquez J, Gallo A et al. Effects of recurrence on the cognitive performance of patients with bipolar I disorder: implications for relapse prevention and treatment adherence. Bipolar Disord 2010; 12: 557-567.
46. Kozicky JM, Torres IJ, Silveira LE, Bond DJ, Lam RW, Yatham LN. Cognitive change in the year after a first manic episode: association between clinical outcome and cognitive performance early in the course of bipolar I disorder. J Clin Psychiatry 2014; 75: e587-e593.
47. Strejilevich SA, Samame C, Martino DJ. The trajectory of neuropsychological dysfunctions in bipolar disorders: a critical examination of a hypothesis. J Affect Disord 2015; 1: 396-402.
48. Budde M, Schulze TG. Neurocognitive correlates of the course of bipolar disorder. Harv Rev Psychiatry 2014; 22: 342-347.
49. Bowie CR, Depp C, McGrath JA et al. Prediction of real-world functional disability in chronic mental disorders: a comparison of schizophrenia and bipolar disorder. Am J Psychiatry 2010; 167: 1116-1124.
50. Tse S, Chan S, Ng KL, Yatham LN. Meta-analysis of predictors of favorable employment outcomes among individuals with bipolar disorder. Bipolar Disord 2014; 16: 217-229.
51. Reinares M, Papachristou E, Harvey P et al. Towards a clinical staging for bipolar disorder: defining patient subtypes based on functional outcome. J Affect Disord 2013; 144: 65-71.
52. Rosa AR, Mercade C, Sanchez-Moreno J et al. Validity and reliability of a rating scale on subjective cognitive deficits in bipolar disorder (COBRA). J Affect Disord 2013; 150: 29-36.
53. Demant KM, Vinberg M, Kessing LV, Miskowiak KW. Assessment of subjective and objective cognitive function in bipolar disorder: correlations, predictors and the relation to psychosocial function. Psychiatry Res 2015; 229: 565-571.
54. Pallanti S, Quercioli L, Pazzagli A et al. Awareness of illness and subjective experience of cognitive complaints in patients with bipolar I and bipolar II disorder. Am J Psychiatry 1999; 156: 1094-1096.
55. Lewandowski KE, Sperry SH, Cohen BM, Ongur D. Cognitive variability in psychotic disorders: a cross-diagnostic cluster analysis. Psychol Med 2014; 44: 3239-3248.
56. Sole-Padulles C, Bartres-Faz D, Junque C et al. Brain structure and function related to cognitive reserve variables in normal aging, mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 2009; 30: 1114-1124.
57. Stern Y. Cognitive reserve. Neuropsychologia 2009; 47: 2015-2028.
58. Forcada I, Mur M, Mora E, Vieta E, Bartres-Faz D, Portella MJ. The influence of cognitive reserve on psychosocial and neuropsychological functioning in bipolar disorder. Eur Neuropsychopharmacol 2015; 25: 214-222.
59. Martinez-Aran A, Vieta E. Cognition as a target in schizophrenia, bipolar disorder and depression. Eur Neuropsychopharmacol 2015; 25: 151-157.
60. Torrent C, Bonnin CM, Martinez-Aran A et al. Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study. Am J Psychiatry 2013; 170: 852-859.
61. Vieta E, Torrent C. Functional remediation: the pathway from remission to recovery in bipolar disorder. World Psychiatry (In press).
62. Bonnin CM, Reinares M, Martinez-Aran A et al. Effects of functional remediation on neurocognitively impaired bipolar patients: enhancement of verbal memory. Psychol Med 2015; 21: 1-11.
63. Burdick KE, Ketter TA, Goldberg JF, Calabrese JR. Assessing cognitive function in bipolar disorder: challenges and recommendations for clinical trial design. J Clin Psychiatry 2015; 76: e342-e350.
64. Samame C, Martino DJ, Strejilevich SA. Social cognition in euthymic bipolar disorder: systematic review and meta-analytic approach. Acta Psychiatr Scand 2012; 125: 266-280.
65. Lee J, Altshuler L, Glahn DC, Miklowitz DJ, Ochsner K, Green MF. Social and nonsocial cognition in bipolar disorder and schizophrenia: relative levels of impairment. Am J Psychiatry 2013; 170: 334-341.
66. Samame C, Martino DJ, Strejilevich SA. An individual task meta-analysis of social cognition in euthymic bipolar disorders. J Affect Disord 2015; 1: 146-153.
67. Lahera G, Herrera S, Reinares M et al. Hostile attributions in bipolar disorder and schizophrenia contribute to poor social functioning. Acta Psychiatr Scand 2015; 131: 472-482.
68. Dias VV, Balanza-Martinez V, Soeiro-de-Souza MG et al. Pharmacological approaches in bipolar disorders and the impact on cognition: a critical overview. Acta Psychiatr Scand 2012; 126: 315-331.
69. Vieta E. The influence of medications on neurocognition in bipolar disorder. Acta Psychiatr Scand 2009; 120: 414-415.
70. Kapczinski F, Magalhaes PV, Balanza-Martinez V et al. Staging systems in bipolar disorder: an International Society for Bipolar Disorders Task Force Report. Acta Psychiatr Scand 2014; 130: 354-363.
71. Vieta E. Staging and psychosocial early intervention in bipolar disorder. Lancet Psychiatry 2015; 2: 483-485.
72. Grande I, Berk M, Birmaher B, Vieta E. Bipolar disorder. Lancet 2015; doi: 10.1016/S0140-6736(15)00241-X. [Epub ahead of print].
73. Russo M, Mahon K, Shanahan M, et al. Affective temperaments and neurocognitive functioning in bipolar disorder. J Affect Disord 2014; 169: 51-56.
74. Wu HI, Chang YH, Lai CC, et al. The effect of comorbid anxiety disorder on neuropsychological function in bipolar II disorder. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35: 1841-1845.
75. Vieta E. The bipolar maze: a roadmap through translational psychopathology. Acta Psychiatr Scand 2014; 129: 323-327.